Upgrade to SI Premium - Free Trial

Citi Resumes GlaxoSmithKline (GSK:LN) (GSK) at Neutral

September 3, 2019 3:28 AM
Citi analyst Andrew Baum resumes coverage on GlaxoSmithKline (GSK:LN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Intl Ratings New Coverage

Next Articles